GlassScriptPhysician profile
Gohar Ashraf
NPI 1699937771
$601.96
in general payments reported to CMS, 2019-2025
15 companies · $233 in 2025
The $233 reported for 2025 was more than what 78% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $175 · 2020: $37.80 · 2023: $91.12 · 2024: $65.78 · 2025: $233.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $390.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $389.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $116.72 | 2019-2025 | Gardasil 9, Vaxelis, Vaxneuvance |
| Sanofi Pasteur INC. | $82.31 | 2019-2025 | |
| Ars Pharmaceuticals Operations, INC. | $54.77 | 2025 | Neffy |
| Collegium Pharmaceutical, INC. | $39.64 | 2025 | Jornay Pm |
| Cranial Technologies, INC | $39.58 | 2024-2025 | Doc Band |
| Shire North American Group INC | $37.80 | 2019 | |
| Verrica Pharmaceuticals INC. | $37.72 | 2023-2025 | Ycanth |
| Kaleo, INC. | $37.44 | 2019 | |
| Pfizer INC. | $35.94 | 2023-2025 | |
| Genentech USA, INC. | $33.73 | 2019 | |
| Alk-Abello, INC | $21.76 | 2023 | Grastek, Odactra |
| Aimmune Therapeutics, INC. | $20.22 | 2023 | |
| Gilead Sciences, INC. | $16.91 | 2023 | Veklury |
| Sobi, INC | $13.81 | 2019 | |
| Tris Pharma INC | $13.61 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gohar Ashraf listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.